Page last updated: 2024-11-10

capryloyl salicylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID9838158
SCHEMBL ID82454
MeSH IDM000605046

Synonyms (33)

Synonym
5-octanoyl salicylic acid
5-n-octanoylsalicylic acid
IXIGWKNBFPKCCD-UHFFFAOYSA-N
2-hydroxy-5-octanoylbenzoic acid
2-hydroxy-5-octanoyl-benzoic acid
5f7pjf6aa4 ,
78418-01-6
unii-5f7pjf6aa4
capryloyl salicylic acid
o-octanoyloxybenzoic acid
5-octanoylsalicylic acid
mexoryl sab
capryloyl salicylic acid [inci]
SCHEMBL82454
H1712
benzoic acid, 2-hydroxy-5-(1-oxooctyl)-
AC-31749
2-hydroxy-5-(1-oxooctyl)benzoic acid
AKOS027382907
FT-0762703
DS-14508
2-hydroxy-5-n-octanoylbenzoic acid
2-hydroxy-5-(1-oxooctyl)- benzoic acid
BCP13873
Q209407
5-octanoylsalicylic-acid
A22890
mfcd11846247
CS-0152294
DTXSID801025584
2-hydroxy-5-octanoylbenzoicacid
dr.different vitaacnal tx night
beta-lipohydroxy acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials10 (71.43%)5.53%
Reviews1 (7.14%)6.00%
Case Studies2 (14.29%)4.05%
Observational0 (0.00%)0.25%
Other1 (7.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]